T-cell production depends on the recruitment of hematopoietic progenitors into the thymus. T-cells are among the last of the hematopoietic lineages to recover following bone marrow transplantation (BMT), but the reasons for this delay are not well understood. Under normal physiologic conditions, thymic settling is selective and either CCR7 or CCR9 is required for progenitor access into the thymus. The mechanisms of early thymic reconstitution following BMT, however, are unknown. Here we report that thymic settling is briefly CCR7/CCR9-independent after BMT, but continues to rely on the selectin ligand PSGL-1. The CCR7/CCR9-independence is transient, and by three weeks after BMT these receptors are again strictly required. Despite the normalization of thymic settling signals, the rare bone marrow progenitors that can efficiently repopulate the thymus are poorly reconstituted for at least four weeks after BMT. Consistent with reduced progenitor input to the thymus, intrathymic progenitor niches remain unsaturated for at least ten weeks after BMT. Finally, we show that thymic recovery is limited by the number of progenitors entering the thymus after BMT. Hence, Tlineage reconstitution after BMT is limited by progenitor supply to the thymus.
Introduction
T-cells provide critical immune protection from a range of pathogens. The T-lineage is the slowest to recover following irradiation and bone marrow transplantation (BMT), a delay that impairs immunologic protection of the host. 1 Peripheral T-cell reconstitution after BMT occurs through two mechanisms: one thymus-independent and one thymus-dependent. First, radioresistant host T-cells and donor T-cells provided in the graft homeostatically proliferate in the lymphopenic post-irradiation environment. 2, 3 Although this population expansion can partially correct numerical T-cell defects, the resulting cells are functionally compromised. 4, 5 The functional recovery of the T-lineage relies on the second mechanism: the de novo generation of naïve T-cells in the thymus. 6, 7 The generation of thymus-derived naïve T-cells can take years, and is particularly slow in adults. 1, 2, 8 The reasons for this delay are not fully understood, but have been suggested to involve impaired intrathymic development due to thymic stromal damage from conditioning regimens, age-related thymic involution, and graft-versus-host disease (GVHD).
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The thymus does not contain self-renewing progenitors and therefore requires the importation of circulating bone marrow (BM)-derived progenitors to sustain thymopoiesis. [12] [13] [14] Thymic settling, however, is suggested to be a rare event and the identity of thymic settling progenitors (TSPs) remains unclear. 15 19, 20 Each of these progenitor types, plus additional progenitors, has been demonstrated to possess T-lineage potential. 21, 22 Prethymic hematopoiesis thus provides a multitude of progenitors with the ability to contribute to T-lymphopoiesis.
The process of thymic settling in normal hosts is selective, as only certain BM progenitors possess the capacity to enter the thymus from blood. 23 The chemokine receptors CCR7 and CCR9 underlie part of this selectivity; each receptor independently supports the importation of progenitors into the thymus. [23] [24] [25] [26] [27] Thymic
For personal use only. on April 3, 2017 . by guest www.bloodjournal.org From settling under competitive conditions is near-absolutely restricted in the absence of both receptors. 26, 27 The Pselectin ligand PSGL-1 also supports thymic settling. 28 Subsets of LMPPs and CLPs express functional CCR7
and CCR9, whereas HSCs and MPPs do not. 23, 27 Consistently, all thymic settling capacity effectively resides within the BM Lin -Kit + Flt3 high pool, which includes both Kit high LMPPs and Kit low CLPs but excludes HSCs and MPPs. 23, 29, 30 These Lin -Kit + Flt3 high progenitors undergo Notch-dependent differentiation into early thymic progenitors (ETPs) upon thymic entry. 31, 32 ETPs generate CD4/CD8 double-negative 2 (DN2) cells and then DN3 cells. After β-selection, DN3 cells become CD4/CD8 double-positive (DP) cells; following positive selection, DP cells give rise to CD4 and CD8 single-positive (SP) thymocytes, which emigrate from the thymus to comprise the peripheral naïve T-cell pool.
Our present knowledge of molecules that mediate normal thymic settling derives from unirradiated hosts, but thymic settling after irradiation is not well understood. Irradiation is often used as part of a cytoablative conditioning regimen prior to BMT. 33 After irradiation, radioresistant intrathymic precursors proliferate and differentiate to initially reconstitute the thymus. 34, 35 These host thymocytes do not self-renew, and long-term thymopoiesis after BMT requires thymic settling by donor progenitors. However, the effects of irradiation on the signals and cells involved in thymic settling are not known.
We investigated the mechanisms of early thymic reconstitution following BMT. We found that the requirement for CCR7 and CCR9 in thymic settling is relaxed acutely following irradiation, though PSGL-1 retains a key role. This initial stage of CCR7/CCR9-independent thymic settling is temporary, and a strict requirement for these receptors is restored by three weeks after irradiation. BM progenitors that can efficiently repopulate the thymus are poorly reconstituted for at least four weeks following BMT. Furthermore, the intrathymic progenitor niche remains unsaturated for at least 10 weeks after BMT, suggesting that impairments prior to thymic entry limit T-lineage reconstitution. Indeed, we find that the delivery of more progenitors into the thymus by direct intrathymic transfer enhances thymic recovery. These data establish that the mechanisms of thymic settling after irradiation vary from those in normal mice. Furthermore, they indicate that limited entry of hematopoietic progenitors into the thymus after BMT impairs T-cell recovery. Animal experiments were performed according to approved protocols of the Office of Regulatory Affairs at the University of Pennsylvania in accordance with National Institutes of Health guidelines.
Cell preparations, flow cytometry, cell sorting
BM and thymocytes were collected as previously described. 27 Antibodies (Abs) in the Lin cocktail included:
and anti-γδTCR (GL-3). Additional Abs used included anti-CD45.2 (104), anti-CD45.1 (A20), anti-Kit (2B8),
anti-Sca1 (D7), anti-Flt3 (A2F10), anti-IL-7Rα (A7R34), anti-CD25 (PC61.5), and anti-CD4 (RM4-5). Abs were purchased from eBioscience, BD Pharmingen, and Biolegend.
BM was sorted on a FACSAria II (BD Biosciences). An LSRII (BD Biosciences) was used for FACS analysis. Dead cells were excluded through DAPI (4',6-diamidino-2-phenylindole) uptake. Doublets were excluded through FSC-H by FSC-W and SSC-H by SSC-W parameters. Data were analyzed using FlowJo software (Tree Star).
Intravenous and intrathymic transfers
For intravenous transfers into unirradiated mice, 1.4x10 7 T-cell-depleted BM cells were injected retro-orbitally.
To prevent rejection, mice were given 0.1 mg anti-CD4 (GK1. 
OP9-DL4 cultures
Sorted progenitors were placed onto OP9-DL4 stromal layers (gift of J.C. Zuniga-Pflücker) as previously described.
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Vascular permeability studies
Mice were irradiated (1.5 Gy or 9.5 Gy) 24 hours before injection of Evans blue (Sigma) or injected intraperitoneally with 5µg/g LPS (Sigma) 30 minutes after injection of Evans blue. Mice were intravenously injected with 20µg Evans blue per gram of body weight. After 2.5 hours, anesthetized animals were exsanguinated and perfused with PBS to clear intravascular Evans blue. The thymus and one lobe of the lung were removed from each mouse, weighed, and homogenized in PBS. Evans blue was extracted by formamide for 24 hours at 55°C. Absorbances of extracted Evans blue at 620nm and 740nm were read on a spectrophotometer (BioRad SmartSpec3000). The concentrations of extracted Evans blue were calculated as previously described.
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Immunofluorescence microscopy
Thymi were cryosectioned into 30µm sections by the Wistar Institute Histotechnology Core. Sections were stained with anti-CD31 antibody (MEC13.3) purchased from Biolegend. Images were obtained from a widefield microscope (Zeiss Axioplan2) coupled to a camera (Zeiss AxioCam) and processed with Image J software.
Statistical anaylsis
p values were calculated using Microsoft Excel by Student's t-test. All experiments are representative of three or more independent experiments with the exception of the experiment in Figure 3 , which was performed twice. Figure 1A-B ). Yet ten weeks after irradiation, only a trace contribution to the DP pool from CCR7/CCR9 DKO cells was detected. The absence of CCR7/CCR9 DKO DP cells at this time is not due to an intrathymic developmental defect; we previously showed that intrathymically transferred CCR7/CCR9 DKO progenitors have no defect in generating downstream progeny. 27 We also examined these chimeras at two and four weeks after BMT. Donor CCR7/CCR9 DKO chimerism and donor WT chimerism within the DP pool became significantly different until at the four week time-point ( Figure 1B ). CD45.2 chimerism of the BM granulocyte (SSC high Gr-1 + ) pool was equivalent between the two cohorts across all time points, ensuring similar BM engraftment. Together these data indicate that thymic settling can occur independently of CCR7 and CCR9 acutely after irradiation.
The detection of CCR7/CCR9 DKO thymocytes at early times, but not ten weeks, after BMT implies that the CCR7/CCR9-independent thymic settling induced by irradiation is temporary. To determine the length of this CCR7/CCR9-independent period, we generated irradiation chimeras into which the CCR7/CCR9 DKO BM was injected at various time points after irradiation ( Figure 1C Figure 1D ). CCR7/CCR9 DKO chimerism and WT donor chimerism were comparable at all time points except in mice receiving donor cells three weeks after BMT, in which CCR7/CCR9 DKO chimerism was modestly reduced. Similar levels of CD45.2 donor chimerism among thymic DP cells were observed between the groups receiving cells on the day of irradiation ( Figure 1E ). In mice receiving donor cells one to four days following irradiation, substantial CCR7/CCR9 DKO chimerism continued to be observed, though reduced compared to the WT control. Among mice receiving CCR7/CCR9 DKO BM cells one week after BMT, only three of six recipients had donor chimerism greater than 1%; at the two week time point, this fraction fell to one of six. Only trace donor chimerism was detected in all mice receiving CCR7/CCR9 DKO cells three weeks after BMT. These data suggest that a role for CCR7 and CCR9 in thymic settling is evident within the first four days, but a strict requirement for these molecules is not reinstated until between two and three weeks after irradiation.
Notably, the absence of CCR7/CCR9 DKO donor chimerism in some recipients in the one and two week groups suggests that there is variability in the duration of CCR7/CCR9-independent thymic settling, and a strict requirement for these receptors can occur within one week of irradiation.
It is possible that after irradiation, physical damage to the thymic vasculature allows for unregulated entry of circulating T-cell progenitors. Indeed, high dose irradiation can damage lung and skin endothelium. 38, 39 We examined the thymic vasculature by immunofluorescence microscopy and found that thymic vascular elements appeared grossly intact one day after irradiation (Supplemental Figure 1A) . We next examined whether irradiation affects thymic vascular permeability by intravenously injecting albumin-binding Evans blue one day after irradiation. Increased vascular permeability to Evans blue was observed in both thymus and lung following a 9.5 Gy dose of irradiation, but not a low dose of 1.5 Gy (Figure 2A ). 1.5 Gy is a sufficient dose, however, to confer CCR7/CCR9-independence on thymic settling ( Figure 2B ), indicating that permeability to Evans blue can be uncoupled from CCR7/CCR9-independent thymic settling. We further asked whether erythrocytes could enter an irradiated thymus, which would be expected if endothelial barrier function had been lost. Following irradiation with 9.5 Gy, there was no detectable increase in the number of erythrocytes in the thymus
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To evaluate whether thymic entry remains regulated after irradiation, we investigated whether another signal important for normal thymic settling, namely PSGL-1, 28 remains relevant. We sought to confirm a role for PSGL-1 in the unirradiated scenario through the adoptive transfer of unfractionated PSGL-1 -/-BM or WT BM (both CD45.2) into unirradiated CD45.1 WT hosts. Three weeks after transfer, the donor chimerism of BM granulocytes was similar in the two cohorts, indicating equivalent engraftment of the BM ( Figure 2C ). The donor chimerism of DN3 cells in recipients of PSGL-1 -/-BM was reduced compared to recipients of WT BM, consistent with a role for PSGL-1 in unirradiated thymic settling. The role of PSGL-1 in thymic settling after BMT was tested through the generation of mixed BM chimeras using mixtures of PSGL-1 -/-BM or WT BM (both CD45.2) and competitor CD45.1 WT BM. Three weeks after BMT, PSGL-1 -/-donor chimerism was equal to WT donor chimerism in the BM granulocyte pool, but significantly reduced among thymic DN3 cells ( Figure   2D ). We found similar reductions at two and four weeks after BMT as well (Supplemental Figure 2 ). These data demonstrate that a role for PSGL-1 -/-in generating thymocytes is maintained after irradiation. To distinguish between a thymic settling defect and an intrathymic developmental defect in the absence of PSGL-1, sorted PSGL-1 -/-or WT LMPPs were intrathymically injected into sublethally irradiated WT hosts, bypassing the thymic settling step. Consistent with past work, 28 PSGL-1 -/-progenitors were not defective at generating downstream DN3 cells, thereby indicating that early intrathymic development is not reliant on PSGL-1 (Supplemental Figure 3) . Together these data demonstrate that unlike CCR7 and CCR9, PSGL-1 maintains its role in thymic settling acutely following BMT.
Collectively, these results indicate that thymic reconstitution after BMT can be divided into three stages:
an acute stage until day four post-BMT during which most thymic reconstitution is CCR7/CCR9-independent; a transitional stage between day four and three weeks during which most reconstitution depends on CCR7/CCR9 although these receptors are not strictly required; and a chronic stage beginning at three weeks requiring CCR7/CCR9 in all cases. Figure 4A-B) . Additionally, since total BM cellularity is very low early after transplantation, these Kit + Flt3 high cells had even more severe defects in absolute number ( Figure 4B ). Impaired reconstitution of these cells continued to be evident four weeks after irradiation, though the magnitudes of the defects were not as severe as at two weeks ( Figure 4B) Figure 4A-B) . Frequencies of MPPs and common myloid progenitors were also decreased, but the frequencies of granulocyte-macrophage progenitors and megakaryocyte-erythroid progenitors were not (Supplemental Figure 4A) .
We assessed the ability of progenitors from post-BMT mice to generate T-lineage (CD25 + Thy1 + ) progeny in vitro using co-culture with OP9 stromal cells expressing the Notch ligand DL4 (OP9-DL4). 36 Unfractionated donor Lin -progenitors sorted from post-BMT mice generated fewer T-lineage progeny than progenitors from unirradiated mice (Supplemental Figure 5A- Figure 5C ). These data indicate that the reduced number of T-lineage cells generated by unfractionated Lin -progenitors from post-BMT mice is attributable to the reduced frequency of Kit + Flt3 high cells, and not to an intrinsic proliferative defect of these progenitors. Together these data indicate that the reconstitution of efficient T-lineage progenitors in the BM is impaired following BMT.
An unsaturated intrathymic progenitor niche persists for at least ten weeks following BMT
The reduced numbers of BM Lin -Kit + Flt3 high progenitors competent to settle the thymus suggested that the frequency of thymic settling may be reduced after BMT. Indeed, a previous report noted that the thymus is nearly devoid of ETPs and DN2 cells for at least four weeks after BMT. 40 However, this deficit of Kit high intrathymic progenitors does not alone demonstrate that thymic settling is reduced; it is possible that intrathymic mechanisms impair the generation or survival of these progenitors. To distinguish between these possibilities, we investigated whether the scarcity of Kit high thymic progenitors reflected a vacant intrathymic progenitor niche after BMT. We first confirmed the near-absence of ETPs and DN2 cells in mice two weeks
For personal use only. on April 3, 2017. by guest www.bloodjournal.org From after BMT and noted the resemblance of these thymi to those of CCR7/CCR9 DKO mice, a strain which has highly inefficient thymic settling. 26, 27 Both have severe defects in the frequencies of ETPs and DN2 cells, but the frequency of DN3 cells is normal ( Figure 5A ). We have previously shown that progenitors placed into CCR7/CCR9 DKO thymi undergo compensatory proliferation, presumably due to reduced competition for progenitor niches. 27 We therefore hypothesized that if the reduced number of Kit high thymic progenitors in post-BMT mice reflects a vacant intrathymic progenitor niche, cells transferred into post-BMT thymi should also expand in a compensatory manner. Sorted BM Lin -Kit + Flt3 high cells were intrathymically injected into hosts that had undergone BMT two weeks earlier or into unirradiated controls. We analyzed host mice two weeks after intrathymic injection, as this is a time point by which significant numbers of donor DN3 and DP cells have been generated. At this time, cells transferred into "pre-transplanted" hosts had generated 25-fold more donor DN3 cells and 190-fold more donor DP cells ( Figure 5B-C) . Similar experiments were performed with hosts that had been transplanted four or ten weeks before intrathymic injection ( Figure 5C ). In both cases, cells placed in pretransplanted hosts generated significantly more downstream DN3 and DP progeny than cells injected into unirradiated hosts. The magnitudes of these differences, however, became progressively smaller as the time between BMT and intrathymic injection grew longer. These data demonstrate that progenitors placed into post-BMT thymi undergo compensatory expansion. We interpret this to signify the presence of unsaturated intrathymic progenitor niches in post-BMT thymi extending at least ten weeks after transplantation. Hence, the reinstatement of normal thymic settling signals is decoupled from the maintenance of a saturated intrathymic progenitor niche following BMT.
Early thymic reconstitution is limited by the number of progenitors delivered to the thymus
The persistence of an unsaturated progenitor niche suggested that thymic reconstitution may be limited by the number of progenitors that settle the thymus after BMT. 11 To address this, we generated non-competitive irradiation chimeras in which CD45.1 WT hosts were transplanted with different doses of CD45.2 BM. A previous study used a similar approach to address this question. 41 We examined recipient thymi two weeks after
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BMT and found that the numbers of donor-derived DN3 and DP cells directly correlated with the BM dose given (Supplemental Figure 6A-B) . While total (donor plus host) DN3 cell number also correlated with BM dose, total DP cell number did not because at two weeks after irradiation, the majority of DP cells are comprised of the progeny of radioresistant host thymocytes. 35 Mice analyzed four weeks after BMT also revealed dose-dependent thymic reconstitution (Supplemental Figure 6C-D) . These data indicate that the magnitude of early thymic reconstitution is limited by the BM dose provided at the time of transplant.
We next tested whether the enhanced thymic recovery observed after high-dose BMT was due to an increased number of donor progenitors entering the thymus. Recipient CD45.1 WT mice were first sublethally irradiated and intravenously inoculated with 2. mice. An important implication of this observation is that acutely irradiated hosts are not appropriate models with which to study the mechanisms of normal unirradiated thymic settling. Conversely, models of physiological thymic settling are a poor approximation for the mechanisms at play in regeneration after BMT.
Thymic settling by circulating progenitors likely uses mechanisms analogous to those used by mature lymphocytes to enter lymph nodes, wherein chemokine signals induce the conformational change of integrins to a high-affinity state. 21 The irrelevance of CCR7 and CCR9 towards thymic settling acutely after BMT presents two alternative mechanisms of progenitor entry into the thymus. First, cells may access the irradiated thymus independently of any chemokine receptor signals. Recent work has demonstrated that irradiation can damage BM sinusoids, making them discontinuous and consequently hemorrhagic. 42, 43 However, the lack of thymic vascular permeability to Evans blue after 1.5 Gy (a dose sufficient to confer CCR7/CCR9-independent thymic settling) (Figure 2A-B) and the continued reliance on PSGL-1 acutely following BMT ( Figure 2D and Supplemental Figure 2 ) together indicate that a loss of endothelial barrier function does not underlie CCR7/CCR9-independent thymic settling. Additionally, an absence of appropriate chemokines appears not to be the cause of CCR7/CCR9-independent settling, since expression of CCL21 and CCL25, ligands for CCR7
For personal use only. on April 3, 2017. by guest www.bloodjournal.org From and CCR9 respectively, are upregulated on thymic stromal cells after irradiation. 44 We speculate that a different chemokine receptor substitutes for CCR7 and CCR9 acutely after irradiation. Irradiation can cause endothelial responses similar to those seen with inflammation, such as the upregulation of adhesion molecules. 45 Such changes could lead to the expression of chemokines not normally associated with the thymic endothelium.
Another possibility is that the defective reconstitution of Kit + Flt3 high BM progenitors (Figure 3 ) limits the number of efficient CCR9 + progenitors, 23 which may allow less efficient CCR9 -cells to settle the thymus.
Additional study is needed to identify which of these mechanisms is at work in the days after BMT.
Efficient thymocyte generation capacity two weeks after BMT resides in the BM Lin -Kit + Flt3 high pool, which contains cells expressing CCR7 and CCR9. The available supply of these progenitors in the BM is significantly diminished following BMT. Therefore the re-imposition of a requirement for CCR7/CCR9 in thymic settling likely reduces the number of progenitors entering the thymus following BMT -effectively "starving" the thymus. We consider the chronic vacancy of the intrathymic progenitor niche to demonstrate that progenitor input into the thymus limits T-lineage reconstitution. Our observation that the intrathymic progenitor niche remains unsaturated ten weeks after BMT further suggests the possibility that the niche may never return to a saturated state. In other words, diminished delivery of progenitors to the thymus may permanently limit Tcell recovery following BMT.
The reduced delivery of progenitors into the thymus after BMT could have multiple causes. The prethymic mechanisms in T-cell development can be considered as three sequential steps. 23 First, the generation of BM progenitors with thymic settling capacity, then the mobilization of these cells from the BM into the blood, and finally the entry of these circulating progenitors into the thymus. We evaluated the first step and found that the rare Lin -Kit + Flt3 high BM subset with efficient thymic repopulating ability is poorly reconstituted, and this impairment persists for at least a month after BMT. The reasons for the defective regeneration of the BM Lin -Kit + Flt3 high pool remain unclear; they may involve the altered BM cytokine milieu following irradiation. 46 Additional prethymic defects in T-lineage reconstitution remain possible, such as decreased mobilization or thymic settling of these progenitors.
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Thymic reconstitution after BMT was thought to be hampered by three major causes: 1) thymic stromal damage from conditioning (radiation or chemotherapeutic drugs); 2) thymic involution in adults; and 3) GVHD targeting the thymus. 10, 11, [47] [48] [49] We have investigated the ability of the thymus to generate T-cells after BMT, but certain caveats exist. We used young mice as hosts, and therefore our results may not be representative of thymic reconstitution in aged humans with involuted thymi. Furthermore, we have used a syngeneic transplant model and thus have avoided any defects that GVHD could have caused. Nevertheless, we found that despite lethal irradiation, the thymus was quite capable of supporting the extensive expansion of donor cells provided intravenously or intrathymically. This does not exclude the possibility that the thymi were impaired relative to unirradiated counterparts. Rather, we interpret this result to mean that donor thymocyte generation in the irradiated thymus benefits from the lack of competition more than it suffers from stromal damage.
The three proposed mechanisms of delayed T-lineage reconstitution noted above all occur at the level of the thymus; we now demonstrate that mechanisms prior to thymic entry also contribute. Consistent with an earlier study, 41 we found that increasing the number of progenitors delivered to the thymus, either 
